We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+14.5%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$59B
AUM Growth
+$9.67B
(+20%)
Cap. Flow
+$3.02B
Cap. Flow
% of AUM
5.11%
Top 10 Holdings %
Top 10 Hldgs %
26.45%
Holding
2,790
New
663
Increased
538
Reduced
776
Closed
680
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.43B |
| 2 |
Amazon
AMZN
|
+$601M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$414M |
| 4 |
D.R. Horton
DHI
|
+$305M |
| 5 |
Intel
INTC
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$905M |
| 2 |
NVIDIA
NVDA
|
+$592M |
| 3 |
Advanced Micro Devices
AMD
|
+$439M |
| 4 |
Amgen
AMGN
|
+$385M |
| 5 |
Adobe
ADBE
|
+$382M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.79% |
| 2 | Consumer Discretionary | 13.23% |
| 3 | Healthcare | 12.61% |
| 4 | Financials | 7.44% |
| 5 | Communication Services | 6.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1776
Coherus Oncology
CHRS
$225M
| $390K | ﹤0.01% |
117,180
-2,195,026
| -95% | -$5.88M |
|
|
NSLR
1777
Neostellar Capital Corp
NSLR
$270M
| $389K | ﹤0.01% |
+98,670
| New | +$394K |
|
1778
VanEck Biotech ETF
BBH
$397M
| $388K | ﹤0.01% |
+2,350
| New | +$362K |
|
1779
Ecovyst
ECVT
$1.34B
| $388K | ﹤0.01% |
39,717
-482,761
| -92% | -$4.6M |
|
1780
AB InBev
BUD
$156B
| $387K | ﹤0.01% |
+5,993
| New | +$354K |
|
1781
Outdoor Holding Co
POWW
$250M
| $387K | ﹤0.01% |
184,100
| – | – |
|
1782
FMC
FMC
$1.39B
| $385K | ﹤0.01% |
+6,100
| New | +$354K |
|
|
AFMD
1783
DELISTED
Affimed
AFMD
| $383K | ﹤0.01% |
+60,730
| New | +$252K |
|
1784
Vail Resorts
MTN
$5.28B
| $381K | ﹤0.01% |
1,784
-13,035
| -88% | -$2.86M |
|
1785
Ametek
AME
$55.7B
| $379K | ﹤0.01% |
+2,300
| New | +$351K |
|
1786
NewAmsterdam Pharma
NAMS
$3.53B
| $379K | ﹤0.01% |
33,941
+23,777
| +234% | +$218K |
|
1787
Saratoga Investment
SAR
$316M
| $379K | ﹤0.01% |
14,656
-44,319
| -75% | -$1.11M |
|
1788
Arlo Technologies
ARLO
$1.51B
| $378K | ﹤0.01% |
+39,693
| New | +$363K |
|
1789
Skywest
SKYW
$4.37B
| $377K | ﹤0.01% |
+7,225
| New | +$325K |
|
1790
Adtran
ADTN
$769M
| $375K | ﹤0.01% |
51,120
-5,372
| -10% | -$35.4K |
|
1791
RLX Technology
RLX
$2.49B
| $375K | ﹤0.01% |
187,600
| – | – |
|
|
CVAC
1792
DELISTED
CureVac
CVAC
| $375K | ﹤0.01% |
89,100
-27,791
| -24% | -$151K |
|
1793
Restaurant Brands International
QSR
$25.8B
| $375K | ﹤0.01% |
4,800
-4,897
| -51% | -$341K |
|
|
AGTI
1794
DELISTED
Agiliti Inc
AGTI
| $375K | ﹤0.01% |
+47,337
| New | +$321K |
|
1795
Coca-Cola Europacific Partners
CCEP
$48.1B
| $374K | ﹤0.01% |
5,600
-29,527
| -84% | -$1.81M |
|
1796
Invesco S&P MidCap Quality ETF
XMHQ
$5.44B
| $371K | ﹤0.01% |
+4,180
| New | +$343K |
|
|
DAO
1797
Youdao
DAO
$1.91B
| $371K | ﹤0.01% |
94,084
-21,442
| -19% | -$87.7K |
|
|
PL.WS
1798
CALL
DELISTED
Planet Labs PBC Warrants
PL.WS
| $371K | ﹤0.01% |
150,000
-33,344
| -18% | -$7.43K |
|
|
EH
1799
EHang Holdings
EH
$398M
| $370K | ﹤0.01% |
22,000
+100
| +0.5% | +$1.63K |
|
1800
CION Investment
CION
$298M
| $368K | ﹤0.01% |
+32,533
| New | +$346K |
|
Similar funds
Marshall Wace's Q4 2023 Portfolio in Review
As of Q4 2023, Marshall Wace held 2,790 positions worth $59B, up 20% from $49.4B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Marshall Wace deployed $3.02B of net new capital in Q4 2023, opening 663 new positions and adding to 538 existing holdings. Its largest new stake was Qualcomm: 1,674,985 shares worth $242M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Microsoft, an estimated $905M trimmed.
- Marshall Wace's largest Q4 2023 buy was Qualcomm: 1,674,985 shares worth $242M.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q4 2023, an estimated $3.43B increase.
- Marshall Wace's biggest Q4 2023 reduction was Microsoft, cutting an estimated $905M.
- Marshall Wace fully exited VMware, Inc in Q4 2023, selling an estimated $149M.
- Marshall Wace's ten largest holdings make up 26% of its $59B portfolio in Q4 2023.
- Marshall Wace opened 663 new positions and closed 680 in Q4 2023.
- Marshall Wace's portfolio value rose 20% quarter-over-quarter to $59B.
Based on Marshall Wace's 13F filing for Q4 2023, filed 14 Feb 2024.